We are live on
!
Find out more
Haemonetics
309 hedge funds and large institutions have $4.42B invested in Haemonetics in 2024 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 124 increasing their positions, 89 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
39% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 89
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
17% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 42
3.48% more ownership
Funds ownership: 109.15% → 112.62% (+3.5%)
2% more call options, than puts
Call options by funds: $42.5M | Put options by funds: $41.7M
1% more funds holding
Funds holding: 306 → 309 (+3)
2% less capital invested
Capital invested by funds: $4.49B → $4.42B (-$70.9M)
Holders
309
Holders Change
+3
Holders Change %
+0.98%
% of All Funds
4.07%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
49
Increased
124
Reduced
89
Closed
42
Calls
$42.5M
Puts
$41.7M
Net Calls
+$767K
Net Calls Change
-$1.31M
Top Buyers
| 1 |
Neuberger Berman Group
New York
|
+$31.5M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$22.7M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$20.5M |
| 4 |
SCM
SG Capital Management
Chicago,
Illinois
|
+$18.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.5M |
